Form 4 for BNTC Benitec Biopharma Inc.
Accepted 2025-03-28 00:00:00 ET · period of report 2025-03-26 · accession 0000899140-25-000479 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-03-28 | 2025-03-26 | BNTC | Cowen Aaron | 10% | P - Purchase | $13.00 | +900.0K | 1.07M | +540% | +$11.70M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock, par value $0.0001 per share | 2025-03-26 | P | A | 793,800 | $13.00 | 8,793,245 | I See footnotes | — | — | (F2) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. |
| 2 | Common | Common stock, par value $0.0001 per share | 2025-03-26 | P | A | 106,200 | $13.00 | 1,066,764 | I See footnotes | — | — | (F3) Notes are included on Exhibit 99.1. (F1) Notes are included on Exhibit 99.1. |